Folia Parasitologica, vol. 60 (2013), issue 1

Folia Parasitologica 60[1] 28-34 (2013) | 10.14411/fp.2013.004

Induction of prominent Th1 response in C57Bl/6 mice immunized with an E. coli-expressed multi T-cell epitope EgA31 antigen against Echinococcus granulosus

Majid Esmaelizad1,2, Gholamreza Ahmadian1, Khosrow Aghaiypour2, Mehdi Shamsara1, Habibellah Paykari2, Majid Tebianian2
1 National Institute of Genetic Engineering and Biotechnology, Shahrak-e-Pajoohesh, Tehran, Iran
2 Razi Vaccine and Serum Research Institute, Genomics and Genetic Engineering Department, Karaj, Iran

First step in developing an epitope-based vaccine is to predict peptide binding to the major histocompatibility complex (MHC) molecules. We performed computational analysis of unique available EgA31 sequence to locate appropriate antigenic propensity positions. T-cell epitopes with best binding affinity values of < 50% inhibitory concentration were selected using different available servers (Propred and IEDB). Peptides with 100% population coverage were selected. A DNA fragment corresponding to the furin linker enriched in Golgi apparatus was inserted sequentially between each epitope sequences in a synthetic DNA in order to cleave the chimeric protein into four separated peptides. Subsequently, the synthetic DNA was cloned into the pGEX4T-1 and pEGFP-N1 vectors and GST-ChEgA31 was expressed in E. coli strain BL21-DE3. The recombinant protein was detected by western blotting using an HRP-conjugated polyclonal anti-GST antibody. Fusion protein purified by affinity chromatography was used to raise antisera in rabbits. Results in agar gel immunodiffusion assay indicated induction of specific antibodies against multiepitope antigen in the tested rabbits. Cytokine assay was carried out in C57Bl/6 mice and the levels of cytokines were analyzed by sandwich ELISA. Interestingly, production of specific IFN-γ was prominently higher in mice immunized with GST-ChEgA31 and pEGFP-ChEgA31 (650-1 300 pg/ml) compared to control groups. No difference was observed in the level of IL-10 and IL-4 in immunized and GST control group. Challenge study with 500 live protoscolices of Echinococcus granulosus on immunized mice demonstrated protectivity level (50-60%). Based on our results, it appeared that the chimeric protein in the study was able to stimulate T-helper cell-1 (Th1) development and high level of cell mediated immunity in mice.

Keywords: cestoda, Taeniidae, paramyosin related protein (EgA31), cytokines, recombinant vaccine, immunization

Received: December 18, 2011; Accepted: September 26, 2012; Published: February 14, 2013


Attachments:

Download file2013-60-1-28.pdf

File size: 1.49 MB

References

  1. Bass J., Turck C., Rouard A., Steiner D. F. 2000: Furin-mediated processing in the early secretory pathway: sequential cleavage and degradation of misfolded insulin receptors. Proc. Natl. Acad. Sci. USA. 97: 11905-11909 Go to original source... Go to PubMed...
  2. Billiau A., Matthys P. 2009: Cytokine growth factor. Rev. Apr. 20: 97-113
  3. Bauder B., Auer H., Schilcher F., Gabler C., Romig T., Bil ger B., Asp oe ck H. 1999: Experimental investigations on the B and T cell immune response in primary alveolar echinococcosis. Parasite Immunol. 21: 409-421 Go to original source... Go to PubMed...
  4. Chow C., Gauci C.G., Cowman A.F., Lightowlers M.W. 2001: A gene family expressing a host-protective antigen of Echinococcus granulosus. Mol. Biochem. Parasitol. 118: 83-88 Go to original source... Go to PubMed...
  5. Dalton J.P., Brindley P.J., Knox D.P. 2003: Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. Int. J. Parasitol. 33: 621-640 Go to original source... Go to PubMed...
  6. Doytchinova I., Flower D. 2003: The HLA-A2 supermotif: a QSAR definition. Org. Biomol. Chem. 1: 2648-2654 Go to original source... Go to PubMed...
  7. Fraize M., Sarciron M.E., Azzouz S., Issaadi N., Bosquet G., Petavy A.F. 2005: Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice. Parasitol. Res. 96: 113-120 Go to original source... Go to PubMed...
  8. Fu Y., Martinez C., Chalar C. 1999: A new potent antigen from Echinococcus granulosus associated with muscles and tegument. Mol. Biochem. Parasitol. 102: 43-52 Go to original source... Go to PubMed...
  9. Fu Y., Saint-Andre M archal I., Marchal T., Bosquet G., Petavy A.F. 2000: Cellular immune response of lymph nodes from dogs following the intradermal injection of a recombinant antigen corresponding to a 66 kDa protein of Echinococcus granulosus. Vet. Immunol. Immunopathol. 74: 195-208 Go to original source... Go to PubMed...
  10. Guan P., Doytchinova I.A., Zygouri C., Flower D.R. 2003: MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl. Bioinformatics 2: 63-66 Go to PubMed...
  11. Hattotuwagama C.K., Guan P., Doytchinova I.A., Flower D.R. 2004: New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity. Org. Biomol. Chem. 2: 3274-3283 Go to original source... Go to PubMed...
  12. Heath D.D., Koolaard J. 2012: Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine. Parasite Immunol. 34: 40-44 Go to original source... Go to PubMed...
  13. Kakkos S.K., Mouzaki A., Vagianos C.E. 2001: Modifications of the immune system caused by the cestode Echinococcus granulosus: a review. Annals of Gastroenterology. 14: 91-98
  14. Kittelberger R., Reichel M.P., Jenner J. 2002: Evaluation of three enzyme-linked immunosorbent assays (ELISAs) for the detection of serum antibodies in sheep infected with Echinococcus granulosus. Vet. Parasitol. 110: 57-76 Go to original source... Go to PubMed...
  15. Kolaskar A.S., Tongaonkar P.C. 1990: A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276: 172-174 Go to original source... Go to PubMed...
  16. Li B.W., Chandrashekar R., Weil G.J. 1993: Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds. J. Immunol. 150: 1881-1885 Go to PubMed...
  17. Lightowlers M.W., Jensen O., Fernandez E., Iriarte J.A., Woollard D.J., Gauci C.G., Jenkins D.J., Heath D.D. 1999: Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int. J. Parasitol. 29: 531-534 Go to original source... Go to PubMed...
  18. Lightowlers M.W., Lawrence S.B., Gauci C.G., Young J., Ralston M.J., Maas D., Health D.D. 1996: Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol. 18: 457-462 Go to original source... Go to PubMed...
  19. Nara T., Matsumoto N., Janecharut T., Matsuda H., Yamamoto K., Irimura T., Nakamura K., Aikawa M., Oswald I., Sher A. 1994: Demonstration of the target molecule of a protective IgE antibody in secretory glands of Schistosoma japonicum larvae. Int. Immunol. 6: 963-971 Go to original source... Go to PubMed...
  20. Pestka S., Krause C.D., Walter M.R . 2004: Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202: 8-32 Go to original source... Go to PubMed...
  21. Petavy A.F., Hormaeche C., Lahmar S., Ouhelli H., Chabal goity A., Marchal T., Azzouz S., Schreiber F., Alvite G., Sarciron M.E., Maskell D., Esteves A., Bosquet G. 2008: An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study. PLoS Negl. Trop. Dis. 2: 125 Go to original source... Go to PubMed...
  22. Saboulard D., Lahmar S., Petavy A.F., Bosquet G. 2003: The Echinococcus granulosus antigen EgA31: localization during development and immunogenic properties. Parasite Immunol. 25: 489-501. Go to original source... Go to PubMed...
  23. Schoenborn J.R., Wilson C.B. 2007: Regulation of interferongamma during innate and adaptive immune responses. Adv. Immunol. 96: 41-101 Go to original source... Go to PubMed...
  24. Siracusano A., Delunardo F., Teggi A., Ortona E.. 2012: Hostparasite relationship in cystic echinococcosis: an evolving story. Clin. Dev. Immunol.: 639362
  25. Siracusano A., Rigano R., Ortona E., Profumo E., Margutti P., Buttari B., Delunardo F., Teggi A. 2008: Immunomodulatory mechanisms during Echinococcus granulosus infection. Exp. Parasitol. 119: 483-489 Go to original source... Go to PubMed...
  26. Song H.S., Lee S.H., Oh E.H., Park T.H. 2009: Expression, solubilization and purification of a human olfactory receptor from Escherichia coli. Curr. Microbiol. 59: 309-314 Go to original source... Go to PubMed...
  27. Sudireddy C., Subhash C.P. 2009: Serum antibody & Th2 cytokine profiles in patients with cystic echinococcosis. Ind. J. Med. Res. 130: 731-735
  28. Thompson R.C.A. 1995: Biology and systematics of Echinococcus. In: R.C.A. Thompson and A.J. Lymbery (Eds.), Echinococcus and Hydatid Disease. CAB International, Wallingford
  29. Thomas G. 2002: Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell. Biol. 3: 753-766 Go to original source... Go to PubMed...
  30. Wheelock E.F. 1965: Interferon-like virus induced in human leukocytes by phytohemagglutinin. Science 149: 310-311 Go to original source...
  31. Wiwanikit V. 2007: A preliminary report on predicted epitopes of malarial VAR2CSA by bioinformatics method: a clue for further vaccine development. Centr. Eur. J. Immunol. 32: 169-171
  32. Zhang W., Zhang Z., Shi B., Li J., You H., Tulson G., Dang X., Song Y., Yimiti T., Wang J., Jones M.K., McManus D.P. 2006: Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans. J. Infect. Dis. 194: 966-974 Go to original source... Go to PubMed...